One day, next-generation gene therapies could be used to nudge the body’s own cells to make those proteins at precisely the right time and in just the right amount. CU 鶹 biochemistry professor Robert Batey and Alexandria Forbes, Ph.D., founder and CEO of biotech firm MeiraGTx, are teaming up to explore how to do it.